Epidural Morphine for Postoperative Analgesia After Total Knee Arthroplasty
Adult Patients, Total Knee Arthroplasty, Epidural Analgesia
About this trial
This is an interventional supportive care trial for Adult Patients focused on measuring Adults, Unilateral TKA, Single femoral nerve block, Low-dose epidural morphine, Effect of postoperative analgesia, Quality of life
Eligibility Criteria
Inclusion Criteria:
- Adult patients (age of 18 years or older);
- American Society of Anesthesiologists classification I-III;
- Scheduled to undergo unilateral TKA under combined spinal and epidural anesthesia.
Exclusion Criteria:
- Age higher than 90 years old;
- Presence of any contraindication to neuraxial block or peripheral nerve block;
- Continuous use of opioid analgesics during the last month;
- Unable to understand Numeric Rating Scale for pain evaluation or existence of language barrier;
- Severe renal insufficiency (requirement of renal replacement therapy);
- History of asthma;
- Recruited in another clinical trials.
Sites / Locations
- Peking University First Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Epidural morphine
Epidural placebo
Epidural morphine (2 mg morphine in 5 ml normal saline) is administered through the epidural catheter at the end of surgery. Single femoral nerve block is performed with 20 ml of 0.5% ropivacaine under the guidance of ultrasonography and nerve stimulator after surgery. Intravenous morphine analgesia is provided with a patient-controlled analgesia pump which is established with 100 ml of 0.5 mg/mL morphine, programmed to deliver a 2 ml bolus with a lockout interval of 8-10 min and a background infusion of 0.5 mL/h.
Epidural placebo (5 ml normal saline) is administered through the epidural catheter at the end of surgery. Single femoral nerve block is performed with 20 ml of 0.5% ropivacaine under the guidance of ultrasonography and nerve stimulator after surgery. Intravenous morphine analgesia is provided with a patient-controlled analgesia pump which is established with 100 ml of 0.5 mg/mL morphine, programmed to deliver a 2 ml bolus with a lockout interval of 8-10 min and a background infusion of 0.5 mL/h.